IL91598A0 - Etoposide solutions and pharmaceutical compositions containing them - Google Patents

Etoposide solutions and pharmaceutical compositions containing them

Info

Publication number
IL91598A0
IL91598A0 IL91598A IL9159889A IL91598A0 IL 91598 A0 IL91598 A0 IL 91598A0 IL 91598 A IL91598 A IL 91598A IL 9159889 A IL9159889 A IL 9159889A IL 91598 A0 IL91598 A0 IL 91598A0
Authority
IL
Israel
Prior art keywords
etoposide
solutions
pharmaceutical compositions
compositions containing
solution
Prior art date
Application number
IL91598A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL91598A0 publication Critical patent/IL91598A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL91598A 1988-09-12 1989-09-11 Etoposide solutions and pharmaceutical compositions containing them IL91598A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/243,392 US4927638A (en) 1986-10-08 1988-09-12 Etoposide solutions

Publications (1)

Publication Number Publication Date
IL91598A0 true IL91598A0 (en) 1990-04-29

Family

ID=22918600

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91598A IL91598A0 (en) 1988-09-12 1989-09-11 Etoposide solutions and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4927638A (xx)
EP (1) EP0359184B1 (xx)
JP (1) JPH02115126A (xx)
KR (1) KR900004322A (xx)
AT (1) ATE83150T1 (xx)
AU (1) AU616049B2 (xx)
DE (1) DE68903814T2 (xx)
DK (1) DK446889A (xx)
FI (1) FI894225A (xx)
GR (1) GR3006501T3 (xx)
IE (1) IE892898L (xx)
IL (1) IL91598A0 (xx)
PT (1) PT91682B (xx)
ZA (1) ZA896916B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (ko) * 1990-01-19 1991-08-31 디께다 가즈히꼬 에토포시드-2-디메틸아미노 화합물의 동결건조 제제
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
ES2308955T5 (es) * 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
MX9605131A (es) * 1994-04-28 1997-10-31 Bionumerik Pharmaceutical Inc Formulacion estable de lactona de 7-etil-camptotecina y metodo para usar la misma.
AU6390096A (en) * 1995-07-20 1997-02-18 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
WO2000044333A2 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Novel injectable antimalarial compositions of artemisinin
EP1289560A1 (en) * 2000-06-12 2003-03-12 SmithKline Beecham Corporation Novel solid dispersion compositions
US20080171687A1 (en) * 2004-09-16 2008-07-17 Abraxis Bioscience, Inc. Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
CA2648007A1 (en) * 2006-04-24 2007-11-01 Bruce Medical Ab Polymer-based anti-cancer agents
US9011843B2 (en) * 2006-12-14 2015-04-21 Master Supplements, Inc. Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
EP3736319A1 (en) 2014-02-07 2020-11-11 GOJO Industries, Inc. Compositions and methods with efficacy against spores and other organisms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
EP0120907A1 (en) * 1982-10-13 1984-10-10 Aston Molecules Limited Pharmaceutical preparations for use in antitumour therapy
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
JPS60239414A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド溶液の変色抑制方法
JPS60239415A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド注射剤
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤

Also Published As

Publication number Publication date
PT91682B (pt) 1995-05-31
DE68903814D1 (de) 1993-01-21
EP0359184B1 (en) 1992-12-09
DK446889A (da) 1990-03-13
ATE83150T1 (de) 1992-12-15
AU616049B2 (en) 1991-10-17
GR3006501T3 (xx) 1993-06-30
JPH02115126A (ja) 1990-04-27
IE892898L (en) 1990-03-12
EP0359184A1 (en) 1990-03-21
PT91682A (pt) 1990-03-30
DE68903814T2 (de) 1993-04-08
FI894225A (fi) 1990-03-13
FI894225A0 (fi) 1989-09-07
DK446889D0 (da) 1989-09-11
AU4130189A (en) 1990-03-15
KR900004322A (ko) 1990-04-12
US4927638A (en) 1990-05-22
ZA896916B (en) 1991-08-28

Similar Documents

Publication Publication Date Title
IL91598A0 (en) Etoposide solutions and pharmaceutical compositions containing them
HUT52526A (en) Process for producing enzyme-inhibiting dipeptide-urea derivatives and pharmaceutical compositions containing them
HUT47552A (en) Process for producing 10-dihydro-10-deoxo-11-aza-erythronolid a derivatives and pharmaceutical compositions containing them as active components
HUT49316A (en) Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT41790A (en) Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them
HUT51613A (en) Process for producing piperidinyl-benzimidazole derivatives and pharmaceutical compositions containing these compounds
HUT44512A (en) Process for producing bensyl derivatives and pharmaceutical compositions containing them
HUT56098A (en) Process for producing azanaphtalenesultame derivatives and pharmaceutical compositions containing them
HUT59908A (en) Process for producing benzazepine- and benzo-thiazepine derivatives and pharmaceutical compositions containing them
HUT49317A (en) Process for producing 16-dehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT42478A (en) Process for producing gamma-carboline derivatives and pharmaceutical compositions containing them
IL89621A0 (en) Arylpiperazinylalkoxy derivatives of cyclic imides,a process for their preparation and pharmaceutical compounds containing them
CS258888A1 (en) Stable soft gelatine capsules
HUT41392A (en) Process for producing new imidazolyl-alkyl-guanidine derivatives and pharmaceutical compositions containing them
HUT43820A (en) Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them
HUT58739A (en) Process for producing 3-oxo-3-/benzopyrano- or -thiopyrano-pyrazol-3-yl/-propionitril derivatives and pharmaceutical compositions containing them
PH24992A (en) Alkadiene derivatives and pharmaceutical composition containing them
HUT43848A (en) Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents
HUT52493A (en) Process for producing benzopiranol derivatives and pharmaceutical compositions containing them as active components
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
HUT46030A (en) Process for producing citostatic antracyclin-glycoside derivatives and pharmaceutical compositions containing them
HUT49131A (en) Process for producing new pyrazolo- and indazolo-pyridin-amine derivatives and pharmaceutical compositions containing them
HUT52501A (en) Process for producing phenyl-oxy-propanol-amine derivatives and pharmaceutical compositions containing them as active components
IL86437A (en) Pharmaceutical compositions containing nedocromil and derivatives thereof
HUT49569A (en) Process for producing phenoxy-ethyl-amine derivatives and pharmaceutical compositions containing them as active components